Jake Xia
Director/Board Member at Hangzhou Qihan Biotech Co., Ltd.
Jake Xia active positions
Companies | Position | Start | End |
---|---|---|---|
Hangzhou Qihan Biotech Co., Ltd.
Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Director/Board Member | - | - |
Career history of Jake Xia
Former positions of Jake Xia
Companies | Position | Start | End |
---|---|---|---|
Salomon Brothers | Corporate Officer/Principal | - | - |
Morgan Stanley Capital Partners (Private Equity)
Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Corporate Officer/Principal | - | - |
Training of Jake Xia
Massachusetts Institute of Technology | Doctorate Degree |
Northeastern University | Graduate Degree |
Peking University | Undergraduate Degree |
Statistics
International
United States | 5 |
China | 3 |
Operational
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectoral
Finance | 4 |
Consumer Services | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Morgan Stanley Capital Partners (Private Equity)
Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Finance |
Salomon Brothers | Finance |
Hangzhou Qihan Biotech Co., Ltd.
Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Health Services |
- Stock Market
- Insiders
- Jake Xia
- Experience